We are live on ! Find out more
SRTA

Strata Critical Medical Inc

125 hedge funds and large institutions have $250M invested in Strata Critical Medical Inc in 2025 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 41 increasing their positions, 36 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

784% more call options, than puts

Call options by funds: $1.76M | Put options by funds: $199K

14% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 36

2.33% more ownership

Funds ownership: 57.88%60.22% (+2.3%)

5% more capital invested

Capital invested by funds: $239M → $250M (+$10.9M)

9% less funds holding

Funds holding: 137125 (-12)

37% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 27

Holders
125
Holders Change
-12
Holders Change %
-8.76%
% of All Funds
1.52%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
17
Increased
41
Reduced
36
Closed
27
Calls
$1.76M
Puts
$199K
Net Calls
+$1.56M
Net Calls Change
+$4.09M
Name Holding Trade Value Shares
Change
Change in
Stake
QCM
51
Quantinno Capital Management
New York
$347K +$283K +58,558 +433%
CG
52
Caprock Group
Idaho
$341K +$159K +32,783 +86%
Boston Partners
53
Boston Partners
Massachusetts
$321K -$42.1K -8,695 -12%
Stifel Financial
54
Stifel Financial
Missouri
$311K +$4.71K +974 +2%
CS
55
Clear Street
New York
$251K
Franklin Resources
56
Franklin Resources
California
$229K +$231K +47,674 New
Deutsche Bank
57
Deutsche Bank
Germany
$222K +$85.4K +17,657 +62%
T. Rowe Price Associates
58
T. Rowe Price Associates
Maryland
$199K +$34.8K +7,198 +21%
AG
59
Algert Global
California
$198K -$77.2K -15,958 -28%
MIM
60
MetLife Investment Management
New Jersey
$180K +$57.8K +11,951 +47%
AC
61
AXQ Capital
New Jersey
$170K +$170K +35,240 New
SC
62
Shay Capital
New York
$164K +$165K +34,042 New
QT
63
Quantbot Technologies
New York
$163K +$164K +33,931 New
Invesco
64
Invesco
Georgia
$154K -$103K -21,344 -40%
Mirae Asset Global ETFs Holdings
65
Mirae Asset Global ETFs Holdings
Hong Kong
$152K +$9.49K +1,963 +7%
AL
66
Arnhold LLC
New York
$144K
VEA
67
Virtus ETF Advisers
New York
$140K
SOW
68
State of Wyoming
Wyoming
$133K +$75.6K +15,636 +129%
Susquehanna International Group
69
Susquehanna International Group
Pennsylvania
$132K +$38.5K +7,969 +41%
Envestnet Asset Management
70
Envestnet Asset Management
Illinois
$124K
IIM
71
INTECH Investment Management
Florida
$112K -$28.8K -5,955 -20%
Manulife (Manufacturers Life Insurance)
72
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$102K -$5.47K -1,132 -5%
Creative Planning
73
Creative Planning
Kansas
$96.4K +$96.9K +20,041 New
BIG
74
Brooklyn Investment Group
New York
$94.7K +$94.6K +19,562 New
SAM
75
Seelaus Asset Management
New Jersey
$88.3K

SRTA Hedge Fund Activity: Q4 2025 in Review

125 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Strata Critical Medical Inc (SRTA) for Q4 2025, worth a combined $250M — up 4.6% from $239M a quarter earlier.

Sellers outnumbered buyers: 27 funds closed out of SRTA and 17 opened new positions — a net loss of 10 holders — while 36 trimmed existing stakes and 41 added.

The largest buyer was Northern Right Capital Management, opening a new position worth an estimated $13.9M. The largest seller was Cannell Capital, exiting entirely with an estimated $8.09M sold.

  • 125 institutional investors held Strata Critical Medical Inc (SRTA) as of Q4 2025, down from 137 in Q3 2025.
  • Funds reported $250M of Strata Critical Medical Inc stock for Q4 2025, up 4.6% quarter-over-quarter.
  • 17 funds opened new Strata Critical Medical Inc positions in Q4 2025 and 27 closed out, a net change of -10 holders.
  • The largest Strata Critical Medical Inc buyer in Q4 2025 was Northern Right Capital Management, an estimated $13.9M added.
  • The largest Strata Critical Medical Inc seller in Q4 2025 was Cannell Capital, an estimated $8.09M sold.

Based on aggregated 13F filings for Q4 2025.